Amey Chalke, Pharma Research Analyst at JM Financial Institutional Securities, said their preferred order within the pharma sector is hospitals, Contract Development and Manufacturing...
Drug firm Laurus Labs Ltd on Thursday (October 23) has provided its outlook for FY 2026, projecting continued strength in business momentum seen during...
Drugmaker Alkem Laboratories Ltd said on Friday (September 26) it has entered into a business transfer agreement with its wholly-owned subsidiary, Alkem Wellness Ltd, to...
Wockhardt has announced a strategic shift in its operations in the United States, deciding to exit the generics pharmaceutical segment in the country. The...
Wockhardt Ltd is exiting its loss-making US generics business, as it focuses on its new antibiotics drug discovery and insulin portfolios.
The drugmaker said on...